LRRK2 and Parkinson disease: miR-29c-3p differentially expressed between LRRK2 mutation carriers and sporadic PD. miR-425-5p showed a trend. Prediction models based on miRNA signatures (esp. a 4-miRNA panel) predicted group affiliation with high accuracy.